Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 24, 2022, 6:08 p.m.

/zigman2/quotes/200043077/composite

$

34.33

Change

-0.43 -1.24%

Volume

Volume 40,184

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Today's close

$ 32.36

$ 34.76

Change

+2.40 +7.42%

Day low

Day high

$31.11

$35.06

Open

52 week low

52 week high

$30.25

$83.98

Open

Steve E. Krognes

Mr. Steve E. Krognes is an Independent Director at Gritstone bio, Inc., an Independent Director at RLS Global AB and a Treasurer, Chief Financial & Accounting Officer at Denali Therapeutics, Inc. He is on the Board of Directors at Gritstone bio, Inc. and RLS Global AB. Mr. Krognes was previously employed as an Independent Director by Corvus Pharmaceuticals, Inc., a CFO, Senior VP, Regional Head-Finance & IT by Genentech, Inc., a Chairman by Genentech Access To Care Foundation, a Head-Mergers & Acquisitions by Roche Holding AG, and a Director-Mergers & Acquisitions by GiroBank A/S. He also served on the board at The California Academy of Sciences and California Life Sciences Association. He received his undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from Harvard Business School.

Transactions

Date Shares Transaction Value
01/05/2022 2,225   Disposition at $44.75 per share. 99,569
01/03/2022 31,000   Award at $0 per share. 0
08/19/2021 200   Disposition at $50.07 per share. 10,014
08/19/2021 2,085   Disposition at $49.52 per share. 103,250
03/15/2021 1,158   Disposition at $63.67 per share. 73,730
03/15/2021 3,258   Disposition at $62.71 per share. 204,310
03/15/2021 32,326   Disposition at $62.04 per share. 2,005,506
03/15/2021 13,258   Disposition at $61.16 per share. 810,860
02/16/2021 501   Disposition at $66.8 per share. 33,467
02/16/2021 16,616   Disposition at $66.2 per share. 1,099,980
02/16/2021 10,199   Disposition at $65.04 per share. 663,343
02/16/2021 22,684   Disposition at $64.27 per share. 1,457,901
02/11/2021 400   Disposition at $71.43 per share. 28,572
02/11/2021 2,635   Disposition at $70.17 per share. 184,898
02/09/2021 426   Disposition at $75.39 per share. 32,117
02/09/2021 1,022   Disposition at $74.38 per share. 76,017
02/07/2021 4,250   Derivative/Non-derivative trans. at $0 per share. 0
01/15/2021 14,147   Disposition at $73.01 per share. 1,032,873
01/15/2021 8,071   Disposition at $71.99 per share. 581,032
01/15/2021 12,981   Disposition at $70.96 per share. 921,132
01/15/2021 14,801   Disposition at $70.1 per share. 1,037,551
08/21/2020 1,954   Derivative/Non-derivative trans. at $32.87 per share. 64,228
08/20/2020 5,643   Derivative/Non-derivative trans. at $0 per share. 0
03/30/2020 1,428   Disposition at $19.48 per share. 27,818
02/07/2020 4,250   Derivative/Non-derivative trans. at $0 per share. 0
08/21/2019 1,977   Derivative/Non-derivative trans. at $18.59 per share. 36,753
08/20/2019 5,643   Derivative/Non-derivative trans. at $0 per share. 0
12/12/2017 500,000   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Chief Operating Officer & Secretary
Mr. Steve E. Krognes
Treasurer, Chief Financial & Accounting Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.